tiprankstipranks
AstraZeneca PLC (SE:AZN)
:AZN
Sweden Market
AZN
AstraZeneca
RESEARCH TOOLSreports

AstraZeneca (AZN) Stock News & Sentiment

2 Followers
AstraZeneca Wins Strong Shareholder Backing at 2026 AGM
Premium
Company Announcements
AstraZeneca Wins Strong Shareholder Backing at 2026 AGM
3d ago
AZN
AstraZeneca Extends Fasenra’s Runway With New Long-Term Safety Study
Premium
Company Announcements
AstraZeneca Extends Fasenra’s Runway With New Long-Term Safety Study
4d ago
AZN
AstraZeneca: Oncology and CVRM Momentum, Pipeline Progress, and FX Tailwinds Underpin Raised £165 Price Target and Buy Rating
Premium
Ratings
AstraZeneca: Oncology and CVRM Momentum, Pipeline Progress, and FX Tailwinds Underpin Raised £165 Price Target and Buy Rating
5d ago
AZN
AstraZeneca’s New Cancer Combo Trial Signals Steady Progress in Antibody Drug Conjugates
Premium
Company Announcements
AstraZeneca’s New Cancer Combo Trial Signals Steady Progress in Antibody Drug Conjugates
10d ago
AZN
AstraZeneca Reports Strong Liver Cancer Results for Imfinzi–Imjudo Combo in EMERALD-3 Trial
Premium
Company Announcements
AstraZeneca Reports Strong Liver Cancer Results for Imfinzi–Imjudo Combo in EMERALD-3 Trial
10d ago
AZN
AstraZeneca Updates Total Voting Rights and Admits Additional Shares for Employee Schemes
Premium
Company Announcements
AstraZeneca Updates Total Voting Rights and Admits Additional Shares for Employee Schemes
11d ago
AZN
AstraZeneca: Buy Rating on Near‑Term Execution Strength and Undemanding Valuation Ahead of Pipeline‑Driven Re‑Rating
Premium
Ratings
AstraZeneca: Buy Rating on Near‑Term Execution Strength and Undemanding Valuation Ahead of Pipeline‑Driven Re‑Rating
11d ago
AZN
More SE:AZN News >

AZN News on the Web

Trump policies, China's biotech boom are ending Europe's pharma powerhouse era
CNBC
Bearish
Parnassus Value Equity Fund's Strategic Moves: AstraZeneca PLC Takes Center Stage
GuruFocus News
Neutral
AstraZeneca faces China headwinds and key drug launches as two banks back 20% upside
Proactive Investors
Neutral
Jefferies Sticks to Their Buy Rating for AstraZeneca (AZN)
TipRanks News
Neutral
UBS Sticks to Their Buy Rating for AstraZeneca (AZN)
TipRanks News
Neutral
AstraZeneca (AZN) Gets a Buy from Citi
TipRanks News
Bullish
AstraZeneca Wins Strong Shareholder Backing at 2026 AGM
TipRanks News
Neutral
Black Diamond Stock: Weighing Catalysts vs. Concentration
Zacks
Bearish

News Score - Last 7 Days

Positive
SE:AZN
Sector Average
Media Buzz
This Week22 articles
Weekly Average25 articles
News Sentiment
This Week77%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is SE:AZN’s Media Buzz Sentiment?
22 articles about SE:AZN were published this week. In an average week, 25 articles are published.
    What is SE:AZN’s weekly average amount of articles?
    In an average week, 25 articles about SE:AZN are published.
      What is SE:AZN’s News Sentiment?
      77% of articles about SE:AZN were positive this week, compared to its sector average of 68%.
        Healthcare Stocks that are Trending in the News
        AORTArtivion
        NBIXNeurocrine
        STAAStaar Surgical
        SLPSimulations Plus
        OWLTOwlet
        Showing the stocks with the most bullish news sentiment over the past week